Transcranial Photobiomodulation for Executive Function in Bipolar Disorder (TPEB): Study Protocol

Author:

Coelho David Richer Araujo12ORCID,Puerto Aura Maria Hurtado123,Vieira Willians Fernando124ORCID,Lohmann Carlos Alberto12,Shahab Muhammad Hamza12ORCID,Gersten Maia Beth1ORCID,Vahedifard Farzan5ORCID,McEachern Kayla Marie1,Clancy Julie A.1ORCID,Cassano Paolo12ORCID

Affiliation:

1. Division of Neuropsychiatry and Neuromodulation, Massachusetts General Hospital, 149 13th Street (2612), Boston, MA 02129, USA

2. Department of Psychiatry, Harvard Medical School, Boston, MA 02215, USA

3. Department of Biomedical Science, Universidad del Valle, Cali 760042, Colombia

4. Department of Anatomy, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, SP, Brazil

5. Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA 15213, USA

Abstract

Bipolar disorder (BD) is a debilitating psychiatric disorder characterized by mood disturbances and executive function deficits. Impairments in executive function, including impulsivity, significantly impact the daily lives of individuals with BD. Transcranial photobiomodulation (t-PBM) with near-infrared light offers a promising noninvasive neurostimulation approach to improve cognitive function. The Transcranial Photobiomodulation for Executive Function in Bipolar Disorder (TPEB) study aims to explore the potential of t-PBM in individuals with BD and executive function impairments. This study will include 20 adults with BD who will each receive one sham and one t-PBM session on the first day of stimulation (treatment day 1), followed by one daily t-PBM stimulation session for four days (treatment days 2 to 5). Cerebral blood flow changes will be evaluated using functional magnetic resonance imaging. Impulsivity, decision-making, and reward responsiveness will be assessed using the Barratt Impulsiveness Scale, the Iowa Gambling Task, and a gambling task that evaluates reward. The outcomes involve examining changes in cerebral blood flow, improvements in decision-making, and reductions in impulsivity and manic symptoms. The TPEB study aims to provide valuable insights into the potential of t-PBM as a therapeutic intervention to enhance executive function in BD.

Funder

Milken Institute; Bessemer Giving Fund/Baszucki Brain Research Fund

Publisher

MDPI AG

Reference105 articles.

1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 392, 1789–1858.

2. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative;Merikangas;Arch. Gen. Psychiatry,2011

3. Admixture analysis of age at onset in first episode bipolar disorder;Nowrouzi;J. Affect. Disord.,2016

4. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth;Moreno;Arch. Gen. Psychiatry,2007

5. Epidemiology and risk factors for bipolar disorder;Rowland;Ther. Adv. Psychopharmacol.,2018

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3